Mirvaso

Mirvaso is a brand name for the prescription medication brimonidine topical gel. It is primarily used for the treatment of persistent facial erythema (redness) associated with rosacea in adults. Rosacea is a chronic inflammatory skin condition that commonly affects the face.

Mirvaso works by constricting the small blood vessels in the skin, which reduces redness. The active ingredient, brimonidine, is an alpha-2 adrenergic agonist. When applied to the skin, it selectively targets and constricts the superficial blood vessels in the dermis, thereby decreasing the visible facial redness characteristic of rosacea.

The gel is typically applied once daily to the affected areas of the face. It is important to apply it to a clean, dry face and avoid contact with eyes, lips, and inside the nose. Consistent daily application is generally required to maintain its effect.

Common side effects associated with Mirvaso use include skin redness, flushing, burning sensation, and stinging. In some cases, more serious side effects can occur, though they are less common. It is important for patients to discuss any concerns or unusual reactions with their healthcare provider. Mirvaso is not a cure for rosacea, but rather a treatment to manage its visible symptoms, specifically facial redness. Its use should be under the guidance of a qualified medical professional.